Analytical Cellular Pathology
Volume 2015 (2015), Article ID 784612, 10 pages
http://dx.doi.org/10.1155/2015/784612

Research Article

Diphenyl Ditelluride Intoxication Triggers Histological Changes in Liver, Kidney, and Lung of Mice

Sônia Cristina Almeida da Luz,¹ Melissa Falster Daubermann,² Gustavo Roberto Thomé,³ Matheus Mülling dos Santos,³ Angelica Ramos,³ Gerson Torres Salazar,³ João Batista Teixeira da Rocha,³ and Nilda Vargas Barbosa³

¹Departamento de Patologia, Universidade Federal de Santa Maria (UFSM), Campus Universitário, Camobi, 97105-900 Santa Maria, RS, Brazil
²Serviço de Patologia, Hospital Universitário de Santa Maria (UFSM), Campus Universitário, Camobi, 97105-900 Santa Maria, RS, Brazil
³Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria (UFSM), Campus Universitário, Camobi, 97105-900 Santa Maria, RS, Brazil

Received 19 April 2015; Accepted 10 June 2015

Academic Editor: Andrea Stringer

Copyright © 2015 Sônia Cristina Almeida da Luz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Tellurium compounds may be cytotoxic to different cells types. Thus, this work evaluated the effect of diphenyl ditelluride ((PhTe)₂), an organotellurium commonly used in organic synthesis, on the morphology of liver, kidney, and lung. Adult mice were acutely (a subcutaneous single dose: 250 μmol/kg) or subchronically (one daily subcutaneous dose: 10 or 50 μmol/kg for 7 and 14 days) exposed to (PhTe)₂. Afterwards, the histological analyses of liver, kidney, and lungs were performed. Liver histology revealed that the hepatocytes of mice subchronically exposed to (PhTe)₂ presented cytoplasmic vacuolization, hydropic degeneration, and hyperchromatic nuclei. Subchronic exposure to 50 μmol/kg (PhTe)₂ also caused hepatic necrosis. Microvesicular and macrovesicular steatosis were identified in liver of mice acutely exposed to (PhTe)₂. Acute and subchronic intoxication with (PhTe)₂ induced changes on epithelial cells of renal tubules, namely, loss of brush border and cytoplasmatic vacuolization. Atrophy and hypertrophy, cast proteinaceous formation, and acute tubular necrosis were also identified in renal tissue. Mice subchronically exposed to 50 μmol/kg (PhTe)₂ developed intra-alveolar edema and alveolar wall congestion in some areas of lungs. Acute exposure to (PhTe)₂ did not cause histological changes in lungs. Our data show that (PhTe)₂ may be considered a histotoxic agent for liver, kidney, and lung.

1. Introduction

Tellurium (Te) is a rare metalloid, which has been regarded as a toxic and nonessential trace element. It can be found in the environment as elemental and ionic inorganic forms [1, 2]. Methylation of Te inorganic forms can produce and release volatile organic forms of tellurium in the environment. Industrially, Te is obtained as by-product of copper refinement [2, 3]. Te has important applications in several industrial processes, and currently many inorganic Te compounds are used in rubber production, in metallurgy, and in the industry of nanoparticulate semiconductors [4–6]. Concerning organic Te compounds, it is important to highlight their role as reagent in organic synthesis [7]. Although Te has been known to be present in plants and microorganisms as bacteria, and fungi, there is no evidence that Te has biological functions [8]. The investigations regarding the toxicology/pharmacology of Te are still limited in literature; however, the therapeutic and toxic role of Te compounds has received more attention in the last decades. With emphasis on toxicological properties, experimental studies have highlighted the detrimental effects of different Te compounds in several tissues including liver, kidney, and blood [9–11]. Te compounds can induce severe neurodegeneration, which is strongly associated with the demyelination processes via inhibition of enzyme squalene epoxidase [1, 12, 13]. With regard to mechanisms, it has been postulated that the toxic action of Te forms (organic and inorganic) involves their prooxidant potential towards thiol groups from biologically active molecules [10, 14–19]. In a similar way, accumulating evidence has showed that the compound diphenyl ditelluride ((PhTe)₂), an organotellurium used commonly as intermediate in organic synthesis [9], is toxic to different tissues [20–29] and inhibits sulfhydryl containing enzymes in vitro and in vivo [9, 16, 19]. Moreover, (PhTe)₂ exposure has been associated with teratogenic, mutagenic, and genotoxic events [28–30]. Although a growing body of biochemical evidence shows the close relationship between diphenyl ditelluride intoxication and oxidative damage, there are few experimental works characterizing the putative histological changes triggered by the compound in specific mammalian organs. Only few studies have demonstrated that the exposure to certain Te compounds may induce morphological alterations in tissues such as liver, thymus, bone marrow, heart, retina, and kidney [31–33]. Specifically about (PhTe)₂, literature data show that rats exposed to compound develop an accentuated cerebral vacuolization [1, 20]. However, the effects of (PhTe)₂ intoxication on other target organs are still unknown morphologically. Thus, keeping in mind the (PhTe)₂ toxicity and the scarcity of data on its action on the morphology of targets tissues such as liver, kidney and lung, the present study aimed to assess the histology of liver, kidney and lungs of mice exposed acute and subchronically to (PhTe)₂ in order to extend, characterize and confirm morphologically the biochemical toxicity of (PhTe)₂.

2. Materials and Methods

2.1. Materials

Hematoxylin and eosin (H&E) and Periodic Acid-Schiff (PAS) staining were purchased from and acquired from Renylab. Diphenyl ditelluride was synthesized according to the literature method [34] (Paulmier, 1986). Analysis of ¹H NMR and ¹³C NMR spectra showed that diphenyl ditelluride presented analytical and spectroscopic data in full agreement with their assigned structures. The chemical purity of the compounds (99.9%) was determined by CGMS.

2.2. Animals

Adult male Swiss albino mice (25–35 g) from our own breeding colony were used. Animals were kept on a 12 h light/dark cycle, at a room maintained at constant temperature (22 ± 2°C), with free access to food and water and housed in solid plastic-bottomed cages. The animals were used according to the guidelines of the Committee on Care and Use of Experimental Animal Resources, from the Federal University of Santa Maria, Brazil.

2.3. Experimental Protocol

2.3.1. Treatments

The mice were treated for different times and with doses of (PhTe)₂ according to Scheme 1. The animals were randomly divided into control () and (PhTe)₂ () groups; and the experiments were carried out 3 times. Mice in the (PhTe)₂ groups were administered (s.c) once a day with 10 or 50 μmol/kg (for 7 or 14 days) or with a single dose of 250 μmol/kg of (PhTe)₂. The compound was dissolved in DMSO and the control group was treated with the vehicle (DMSO 1 mL/Kg). The choice of (PhTe)₂ doses used in this experimental protocol was based on a previous study [6].

Scheme 1

2.3.2. Tissue Preparation

Twenty-four hours after the end of each experimental period, the animals were euthanized by cervical dislocation. The organs designed for morphological analysis (liver, kidney, and lungs) were quickly removed, rinsed with saline solution (0.9%), and fixed in formalin 10%. The diagonal section of the liver and lung as well as the longitudinal section of the kidney was obtained and processed (Pathology laboratory, Pathology Department of Federal University of Santa Maria). The processed tissues were embedded in paraffin, sectioned at 4 μm thickness, and placed on frosted glass slides for further evaluation. The tissue macroscopic alterations were also analyzed.

The samples were stained using hematoxylin and eosin (H&E) stains [35], which can detect changes in the nucleus and cytoplasm; for instance, degenerative lesions and necrosis. The slides were assessed using a light microscopy coupled to the photomicrographic camera, both adapted to a microcomputer with software Honestech for image capture.

3. Results

3.1. Macroscopic Analysis

In macroscopic examination, we observed that the organs of mice exposed to (PhTe)₂ (independently of dose and period) had a gray-black coloration. This effect was more marked in kidneys, lungs, muscles, and abdominal cavity (Figures 1(a), 1(b), and 1(c)).

(a)

(b)

(c)

Figure 1: Abdominal cavity and organs of mice acutely or subchronically exposed to different diphenyl ditelluride treatments: (a) abdominal cavity of control (left) and diphenyl ditelluride (right) treated mice; (b) kidneys, liver, and lungs of control (left) and diphenyl ditelluride (right) treated mice; (c) muscles of lower limbs of control (left) and diphenyl ditelluride (right) treated mice. The picture is a representation of three independent experiments in all doses tested.

3.2. Microscopic Analysis

3.2.1. Hepatic Tissue

(PhTe) ₂-10 μmol/kg. Liver histopathological analysis showed that the hepatocytes of mice exposed to (PhTe)₂ (10 μmol/kg for 7 days) presented marked cytoplasmic vacuolation (vacuoles of different sizes), hydropic degeneration (intracellular edema), and hyperchromatic nuclei when compared to the control mice (Figure 2). The same kind of morphological changes was found in the liver of mice exposed for 14 days to (PhTe)₂ (data not shown).

(a)

(b)

Figure 2: Liver histological analysis of mice exposed to diphenyl ditelluride 10 μmol/kg for 7 days. (a) Hepatocytes of mice control: cells with normal nuclei, dispersed chromatin and nucleolus arranged towards hepatic central vein (detail in 40x); (b) liver section of mice treated with diphenyl ditelluride showing cytoplasmic vacuolation, edema, and hyperchromatic nuclei (detail in 40x) (H&E 10x). The picture is a representation of three independent experiments.

(PhTe) ₂-50 μmol/kg. In addition to hydropic degeneration, exposure to 50 μmol/kg (PhTe)₂ for 7 days caused hepatic necrosis (Figure 3). The signs of necrosis were evidenced by presence of hepatocytes with pyknotic nuclei and eosinophilic cytoplasm (Figure 3(c)). Aggregation of mononuclear cells in centrilobular (zone 3) and mediolobular areas (zone 2) was also found in the hepatic parenchyma (Figure 3(d)). Similar histological changes were identified in the livers of mice intoxicated with 50 μmol/kg of (PhTe)₂ for 14 days (data not shown).

(a)

(b)

(c)

(d)

Figure 3: Liver histological analysis of mice exposed to diphenyl ditelluride 50 μmol/kg for 7 days. (a) Liver section of control group showing polygonal hepatocytes with oval shaped nuclei, dispersed chromatin, and prominent nucleolus cordially arranged towards hepatic central vein (detail in 40x); (b) liver section of diphenyl ditelluride treated mice showing hepatocytes with manifestation of hydropic degeneration (detail in 40x); (c) pyknotic nuclei and eosinophilic cytoplasm (arrow) (detail in 40x) and (d) mononuclear infiltrate in centrilobular (zone 3) and mediolobular (zone 2) (arrow) areas (H&E 10x). The picture is a representation of three independent experiments.

(PhTe) ₂-250 μmol/kg. Histopathologic analysis revealed that the liver of mice exposed to a single dose of (PhTe)₂ (250 μmol/kg) developed microvesicular and macrovesicular steatosis (Figure 4). Microvesicular steatosis was characterized by presence of small vesicles filling the cytoplasm of the hepatocytes (foamy hepatocytes) and nucleus localized on the cell center. Macrovesicular steatosis was characterized by large vacuoles, apparently “without filling” and rounded by a clear outline (Figure 4(b)). The acute intoxication was also associated with a marked and focal dilatation of sinusoids, which was more prominent in the centrilobular (Zone 3) and mediolobular (Zone 2) areas of the hepatic parenchyma (Figure 4(c)). In some areas a mild venous congestion and hepatocytes with pyknotic nucleus surrounding the congested area were observed (Figure 4(d)). A disorganization of hepatic laminae was also observed in this group when compared to control.

(a)

(b)

(c)

(d)

Figure 4: Liver histological analysis of mice acutely exposed to diphenyl ditelluride 250 μmol/kg. (a) Liver section of control group showing preserved polygonal hepatocytes with oval-shaped nuclei, dispersed chromatin, and prominent nucleolus cordially arranged towards hepatic central vein; (b) liver section of diphenyl ditelluride treated mice showing microvesicular steatosis and macrovesicular steatosis; (c) presence of sinusoidal dilatation mainly in centrilobular and mediolobular areas; (d) hepatocytes with pyknotic nuclei surrounded area with vascular congestion and hepatic laminae disorganized (H&E 10x). The picture is a representation of three independent experiments.

3.2.2. Renal Tissue

(PhTe) ₂-10 μmol/kg. Exposure to (PhTe)₂ (10 μmol/kg for 7 days) caused a prominent degeneration of epithelial cells lining the renal tubules (Figure 5). Degenerative processes were evidenced by presence of edema and epithelial cells with large vacuoles (Figures 5(b) and 5(c)). In several tubules signals of acute tubular necrosis were observed, for instance, an apparent loss of tubular epithelial cells specialization (brush border) and presence of necrotic debris and necrotic epithelial cells in the lumen (Figure 5(c)). Indeed, various renal tubules were filled with eosinophilic homogenous material (cast proteinaceous) and had a marked tubular hypertrophy (Figures 5(c) and 5(d)). The same kind of morphological changes were found in mice treated for 14 days (data not shown).

(a)

(b)

(c)

(d)

Figure 5: Kidney histological analysis of mice exposed to diphenyl ditelluride 10 μmol/kg for 7 days. (a) Kidney section of control group showing conserved architecture of cortex with convoluted tubules outlined for a single layer of cuboidal cells and preserved glomeruli (detail 40x). Kidney section of diphenyl ditelluride treated mice showing (b) vacuolar degeneration represented for marked epithelial cells swelling of renal tubules (detail 40x); (c) dilated distal tubules and proximal tubules in different stages of compression; loss of brush border and some tubular cells free in lumen; (d) hypertrophic tubules filled with eosinophilic homogeneous substance (cast proteinaceous) (H&E 10x). The picture is a representation of three independent experiments.

(PhTe) ₂-50 μmol/kg. The exposure to (PhTe)₂ (50 μmol for 7 days) induced degenerative changes in the lining epithelium of renal tubules, which had cytoplasmatic vacuoles and loss of brush border (Figure 6(b)). Some tubules also presented lumen filled with eosinophilic homogenous material, characterizing the cast proteinaceous formation (Figure 6(c)). Indeed, vascular congestion in cortical and medullar areas was identified (Figure 6(d)). No additional alteration was observed in the kidney of mice exposed to (PhTe)₂ 50 μmol/kg for 14 days (data not shown).

(a)

(b)

(c)

(d)

Figure 6: Kidney histological analysis of mice exposed to diphenyl ditelluride 50 μmol/kg for 7 days. (a) Kidney section of control group showing conserved architecture of cortex with convoluted tubules outlined for a single layer of cuboidal cells and preserved glomeruli; kidney section of diphenyl ditelluride treated mice revealing (b) vacuolar degeneration represented for marked epithelial cells swelling of renal tubules; (c) hypertrophic tubules filled with eosinophilic homogeneous substance (cast proteinaceous) (arrow); and (d) presence of vascular congestion in cortical and medullar areas (circle) (H&E 10x). The picture is a representation of three independent experiments.

(PhTe) ₂-250 μmol/kg. The histological analysis revealed that the renal tubules of mice exposed to a single dose of (PhTe)₂ (250 μmol/kg) contained epithelial cells in the lumen and presented different stages of compression (Figure 7(c)). Also the presence of hypertrophic tubules filled with cast proteinaceous and tubules containing a single layer of epithelial cells and small vacuoles was observed (Figures 7(c) and 7(d)). The occurrence of casts within the hypertrophic tubules was confirmed by PAS staining (Figure 7(e)).

(a)

(b)

(c)

(d)

(e)

Figure 7: Kidney histological analysis of mice exposed acutely to diphenyl ditelluride 250 μmol/kg. Kidney section of control group showing (a) conserved architecture of renal cortex with convoluted tubules outlined for a single layer of cuboidal cells and preserved glomeruli and (b) renal medullar area with collecting tubule of normal morphology. Kidney of diphenyl ditelluride treated mice showing (c) tubules in different stages of compression (arrows), epithelial cells free in tubular lumen; presence of hypertrophic tubules filled with eosinophilic homogeneous substance (cast proteinaceous); (d) presence of tubules containing a single layer of epithelial cells and small vacuoles, presence of tubules filled with eosinophilic homogeneous substance (cast proteinaceous); (e) Kidney section with PAS stain, confirming the presence of cast proteinaceous in hypertrophic tubules (positive PAS stain/detail in 40x) (H&E 10x). The picture is a representation of three independent experiments.

3.2.3. Pulmonary Tissue

(PhTe) ₂-10 μmol/kg. No morphological alteration was observed in the pulmonary tissue of mice exposed to 10 μmol/kg of (PhTe)₂, for 7 or 14 days, when compared with the control group (data not shown).

(PhTe) ₂-50 μmol/kg. Lung histopathology revealed that the exposure to 50 μmol/kg of (PhTe)₂ for 7 days was accomplished by development of edema intra-alveolar and alveolar wall congestion in some areas (Figure 8(b)). Similar tissue changes were observed in the lung of mice exposed to (PhTe)₂ 50 μmol/kg for 14 days (data not shown).

(a)

(b)

Figure 8: Lung histological analysis of mice exposed to diphenyl ditelluride 50 μmol/kg. (a) Lung section of control group showing bronchioles, blood vessels, and adjacent alveoli with normal morphology. (b) Lung section of diphenyl ditelluride treated mice showing the presence of some isolated areas with intra-alveolar edema (arrows) (H&E 10x). The picture represents the sum of three independent experiments.

(PhTe) ₂-250 μmol/kg. The pulmonary analysis showed that the acute exposure to (PhTe)₂ at 250 μmol did not cause changes in alveolar morphology when compared to the control (data not shown).

4. Discussion

Our present work provided evidence that (PhTe)₂ can elicit several histological abnormalities in liver, kidney, and lung of adult mice. In general, (PhTe)₂ exposure caused degenerative lesions of reversible and irreversible character, principally in liver and kidney. In contrast, lung was little affected by (PhTe)₂ intoxication. The macroscopic findings showed that the kidneys, lungs, muscles, and abdominal cavity of mice intoxicated with (PhTe)₂ developed a gray-black coloration. In analogy, a blackened appearance has already been observed in the mucosa of the bladder and ureter during the necropsies analysis of a human fatally poisoned with sodium telluride [36]. In this case report, it was also emphasized that the individual intoxicated by sodium telluride presented a peculiar garlic odor in the breath and severe cyanosis [36]. Although the tissue metabolism of (PhTe)₂ is not well studied, other studies have suggested that the black color of some tissues observed in Te intoxication fatalities possibly reflects the deposition of reduced tellurium or elemental tellurium forms [4, 36].

Currently, the toxicological properties of (PhTe)₂ have been investigated in in vivo and in vitro experimental models. Especially in liver, acute and/or chronic intoxication have been reported to increase the organ-to-body weight ratio, inhibit δ-ALA-D enzyme, increase thiobarbituric acid reactive substances, decrease nonprotein SH levels, and modify antioxidant enzymes activities in rodents [17, 19, 29, 37]. In morphological terms, herein we observed that the liver of animals exposed to (PhTe)₂ (10 and 50 μmol/kg), for few days, contained hepatocytes with extensive cytoplasmic vacuolization, hydropic degeneration (edema), and hyperchromatic nuclei. The excessive accumulation of water associated with cytoplasmatic vacuolization and hydropic degeneration usually results from increased permeability of cell membranes [38]. Indeed, exposure to 50 μmol/kg of (PhTe)₂ induced a focal or nonspecific hepatitis and a focus of necrosis with dispersed cells followed by lymphocytic infiltration. Acute hepatitis with or without cholestasis is the most common histological pattern of drug-induced liver injury (DILI). It is widely recognized that DILI can be mediated by two main mechanisms: intrinsic and idiosyncratic hepatotoxicity. Commonly, intrinsic DILI is accompanied by hepatocellular necrosis and little inflammation, while the idiosyncratic DILI often with inflammation-dominant hepatic injury [39]. The liver of mice exposed acutely to (PhTe)₂ developed marked steatosis and changes consistent with cellular necrosis such as nuclear pyknosis and dense eosinophilic bodies unaccompanied by inflammation. Acute hepatocellular injury may result in necrosis affecting a single (spotty necrosis) or groups of hepatocytes (confluent necrosis). The necrosis signals associated with (PhTe)₂ intoxication were characterized by a confluent necrosis in centrilobular zone (zone 3), that is commonly caused by other drugs such as acetaminophen, halothane, and/or toxins like carbon tetrachloride. Frequently necrosis is accompanied by steatosis, which is characterized by presence of small fatty vesicles filling the cytoplasm of the hepatocyte (foamy hepatocyte) [40]. Here, the macrovesicular steatosis was represented by presence of single, large fat droplets in hepatocytes pushing the nucleus to the periphery of the cell. This change may be derived from the impaired egress of lipid from hepatocyte. Taken together, these sets of results indicate that (PhTe)₂ is a xenobiotic that induces acute hepatitis and cellular death. Although there are little data on the liver histology in models of intoxication by Te compounds, our findings are in accordance with some studies that identified vacuolization and necrosis signals in hepatocytes of rats exposed to tellurium dioxide [41].

In vivo data on the renal deleterious action of (PhTe)₂ are scarce in the literature. Unlike liver and brain, some biochemical analysis show that acute and/or chronic exposure to (PhTe)₂ did not affect the activity of renal sulfhydryl enzyme δ-ALA-D, a marker of oxidative damage [17]. Herein, the intoxication with (PhTe)₂ provoked several renal damage including vacuolar degeneration, atrophy and hypertrophy of renal tubules, hyaline cast formation, and acute tubular necrosis. These events reflect the cytotoxic effect of compound on renal parenchyma, which could impair the process of glomerular filtration and tubular reabsorption. Usually the hydropic changes and vacuolar degeneration appear whenever the cells are incapable of maintaining the ionic and fluid homeostasis. These features are considered the first manifestations of almost all forms of cell injury and characterize a reversible injury type [42]. In renal analysis, the atrophic aspect of tubules was distinguished by a decrease of their size following wrinkling and thickening of basal membrane. Some of atrophic tubules were also filled by cast proteinaceous, a pink mass in the lumen that corresponds to proteins filtered in glomerulus. In addition, the renal tubules of mice exposed subchronically to (PhTe)₂ presented signals of acute tubular necrosis that was identified by presence of cytoplasm fragment projections towards tubular lumen and loosening of some of these microvesicles (“blebbing”), loss of the brush border and some free cells in the lumen. Based on these observations, it is plausible to suppose that (PhTe)₂ exposure induced injuries on the basal membrane, the principal filtration structure, making the glomerulus abnormally permeable. In this way, there is evidence that inorganic Te compounds cause histological changes in the kidneys, ranging from cellular swelling to necrosis [31, 41]. For example, rats intoxicated with tellurium dioxide developed vacuolization of tubular cells and glomerular hemorrhage, followed by albuminuria and hematuria [31].

Regarding (PhTe)₂ exposure and its impact in humans, it is important to consider the growing use of this organochalcogen in the workplace and consequently the increased human exposure risk [9, 34]. In this context, the knowledge about the toxicological role of compound in the lungs is extremely important, since the inhalation is the major route of intoxication in the workplace. Although this route of exposure has not been used in this work and this fact may limit our findings, the results showed here are the first pathological data reporting the effects of (PhTe)₂ on the histology of lungs. Of toxicological importance, a recent study showed that acute exposure to (PhTe)₂ (via s.c, 0.3, 0.6, and 0.9 μmol/kg) caused oxidative damage in rat lungs, which was associated with increase in the levels of lipid peroxidation, reactive species, and nonprotein thiol as well as alterations in antioxidant enzymes activities [43]. In the histology analysis, we verified that, differing from the liver and kidney, the lung of mice intoxicated with (PhTe)₂ by s.c route did not present signals of severe lesions. However, it was possible to observe that (PhTe)₂ exposure induced edema and pulmonary congestion on some areas in the dose of 50 μmol/kg. It has been reported that other Te forms such as cadmium telluride (via intratracheal) and tellurium hexafluoride (via inhalation) cause significant lung changes, including parenchymal inflammation, lung fibrosis, necrosis of bronchiolar epithelium, inflammation of alveolar epithelium, and lung edema [44, 45]. The differences can be explained by the route and type of compounds administered.

In conclusion, our results indicate that (PhTe)₂ exposure provokes important morphological changes in liver, kidney, and lungs and, consequently, it represents a potential risk to human health in the work place. Although the mechanisms involved in (PhTe)₂ responses are still under debate, our data certainly will contribute to extending the knowledge on the toxicology of (PhTe)₂, since it is the first work that evaluates the histology of important organs after intoxication with the compound.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The financial support by FAPERGS/PRONEX/PRONEM, CAPES/SAUX, and CNPq is gratefully acknowledged. João Batista Teixeira da Rocha and Nilda Vargas Barbosa are the recipients of CNPq fellowships.

References

L. Heimfarth, S. O. Loureiro, M. F. Dutra et al., “Disrupted cytoskeletal homeostasis, astrogliosis and apoptotic cell death in the cerebellum of preweaning rats injected with diphenyl ditelluride,” NeuroToxicology, vol. 34, no. 1, pp. 175–188, 2013.

W. C. Cooper, Tellurium, Van Nostrand Reinhod, New York, NY, USA, 1971.

D. C. Dittmer, “Tellurium,” Chemical and Engineering News, vol. 81, no. 36, p. 128, 2003.

S. Duckett and K. A. O. Ellem, “Localization of tellurium in fetal tissues, particularly brain,” Experimental Neurology, vol. 32, no. 1, pp. 49–57, 1971.

M. C. Yarema and S. C. Curry, “Acute tellurium toxicity from ingestion of metal-oxidizing solutions,” Pediatrics, vol. 116, no. 2, pp. 319–321, 2005.

M. Green, H. Harwood, C. Barrowman et al., “A facile route to CdTe nanoparticles and their use in bio-labelling,” Journal of Materials Chemistry, vol. 17, no. 19, pp. 1989–1994, 2007.

N. Petragnani and H. A. Stefani, Tellurium in Organic Synthesis, 2nd edition, 2007.

L. Gerhardsson, J. R. Glover, G. F. Nordberg, and V. Vouk, “Tellurium,” in Handbook on the Toxicology of Metals, L. Friberg, G. F. Nordberg, and V. B. Vouk, Eds., vol. 2, pp. 532–548, Elsevier, Amsterdam, The Netherlands, 2nd edition, 1986.

C. W. Nogueira, G. Zeni, and J. B. T. Rocha, “Organoselenium and organotellurium compounds: toxicology and pharmacology,” Chemical Reviews, vol. 104, no. 12, pp. 6255–6285, 2004.

C. A. S. Carvalho, T. Gemelli, R. B. Guerra et al., “Effect of in vitro exposure of human serum to 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress,” Molecular and Cellular Biochemistry, vol. 9, pp. 182–188, 2009.

D. F. Meinerz, J. Allebrandt, D. O. C. Mariano et al., “Differential genotoxicity of diphenyl diselenide (PhSe)₂ and diphenyl ditelluride (PhTe)₂,” PeerJ, vol. 2, article e290, 2014.

M. Wagner, A. D. Toews, and P. Morell, “Tellurite specifically affects squalene epoxidase: investigations examining the mechanism of tellurium-induced neuropathy,” Journal of Neurochemistry, vol. 64, no. 5, pp. 2169–2176, 1995.

J. F. Goodrum, “Role of organotellurium species in tellurium neuropathy,” Neurochemical Research, vol. 23, no. 10, pp. 1313–1319, 1998.

F. X. Blais, R. T. Onischuk, and R. H. De Meio, “Hemolysis by tellurite. I. The tellurite test for hemolysis,” The Journal of the American Osteopathic Association, vol. 72, no. 2, pp. 207–210, 1972.

B. Deuticke, P. Lütkemeier, and B. Poser, “Tellurite-induced damage of the erythrocyte membrane. Manifestations and mechanisms,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1109, no. 1, pp. 97–107, 1992.

N. V. Barbosa, J. B. T. Rocha, G. Zeni, T. Emanuelli, M. C. Beque, and A. L. Braga, “Effect of organic forms of selenium on -aminolevulinate dehydratase from liver, kidney, and brain of adult rats,” Toxicology and Applied Pharmacology, vol. 149, no. 2, pp. 243–253, 1998.

E. N. Maciel, E. M. M. Flores, J. B. T. Rocha, and V. Folmer, “Comparative deposition of diphenyl diselenide in liver, kidney, and brain of mice,” Bulletin of Environmental Contamination and Toxicology, vol. 70, no. 3, pp. 470–476, 2003.

V. C. Borges, J. B. T. Rocha, and C. W. Nogueira, “Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na(+), K(+)-ATPase activity in rats,” Toxicology, vol. 215, no. 3, pp. 191–197, 2005.

J. B. T. Rocha, R. A. Saraiva, S. C. Garcia, F. S. Gravina, and C. W. Nogueira, “Aminolevulinate dehydratase (δ-ALA-D) as marker protein of intoxication with metals and other pro-oxidant situations,” Toxicology Research, vol. 1, no. 2, pp. 85–102, 2012.

C. W. Nogueira, L. N. Rotta, M. L. Perry, D. O. Souza, and J. B. Teixeira da Rocha, “Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo,” Brain Research, vol. 906, no. 1-2, pp. 157–163, 2001.

B. L. Sailer, N. Liles, S. Dickerson, and T. G. Chasteen, “Cytometric determination of novel organotellurium compound toxicity in a promyelocytic (HL-60) cell line,” Archives of Toxicology, vol. 77, no. 1, pp. 30–36, 2003.

M. B. Moretto, C. Funchal, G. Zeni, J. B. T. Rocha, and R. Pessoa-Pureur, “Organoselenium compounds prevent hyperphosphorylation of cytoskeletal proteins induced by the neurotoxic agent diphenyl ditelluride in cerebral cortex of young rats,” Toxicology, vol. 210, no. 2-3, pp. 213–222, 2005.

E. C. Stangherlin, A. M. Favero, G. Zeni, J. B. T. Rocha, and C. W. Nogueira, “Teratogenic vulnerability of Wistar rats to diphenyl ditelluride,” Toxicology, vol. 207, no. 2, pp. 231–239, 2005.

V. C. Borges, J. B. T. Rocha, L. Savegnago, and C. W. Nogueira, “Repeated administration of diphenyl ditelluride induces hematological disorders in rats,” Food and Chemical Toxicology, vol. 45, no. 8, pp. 1453–1458, 2007.

V. P. P. Schiar, D. B. dos Santos, M. W. Paixão, C. W. Nogueira, J. B. T. Rocha, and G. Zeni, “Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species,” Chemico-Biological Interactions, vol. 177, no. 1, pp. 28–33, 2009.

S. Pinton, C. Luchese, E. C. Stangherlin, S. S. Roman, and C. W. Nogueira, “Diphenyl ditelluride induces neurotoxicity and impairment of developmental behavioral in rat pups,” Journal of the Brazilian Chemical Society, vol. 21, no. 11, pp. 2130–2137, 2010.

B. Comparsi, D. F. Meinerz, J. L. Franco et al., “Diphenyl ditelluride targets brain selenoproteins in vivo: inhibition of cerebral thioredoxin reductase and glutathione peroxidase in mice after acute exposure,” Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 173–182, 2012.

D. Caeran Bueno, D. F. Meinerz, J. Allebrandt et al., “Cytotoxicity and genotoxicity evaluation of organochalcogens in human leucocytes: a comparative study between ebselen, diphenyl diselenide, and diphenyl ditelluride,” BioMed Research International, vol. 2013, Article ID 537279, 6 pages, 2013.

R. Pessoa-Pureur, L. Heimfarth, and J. B. Rocha, “Signaling mechanisms and disrupted cytoskeleton in the diphenyl ditelluride neurotoxicity,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 458601, 21 pages, 2014.

T. H. Degrandi, I. M. de Oliveira, G. S. D'Almeida et al., “Evaluation of the cytotoxicity, genotoxicity and mutagenicity of diphenyl ditelluride in several biological models,” Mutagenesis, vol. 25, no. 3, pp. 257–269, 2010.

S. E. Sandrackaja, Experimental Studies of the Characteristics of Telluriumas an Industrial Poison, First Moscow Medical Institute, Moscow, Russia, 1962.

W. W. Carlton and W. A. Kelly, “Tellurium toxicosis in Pekin ducks,” Toxicology and Applied Pharmacology, vol. 11, no. 2, pp. 203–214, 1967.

A. Nyska, T. Waner, M. Pirak, M. Albeck, and B. Sredni, “Toxicity study in rats of a tellurium based immunomodulating drug, AS-101: a potential drug for AIDS and cancer patients,” Archives of Toxicology, vol. 63, no. 5, pp. 386–393, 1989.

C. Paulmier, “Selenorganic functional groups,” in Selenium Reagents and Intermediates in Organic Synthesis, C. Paulmier, Ed., pp. 25–51, Pergamon Press, Oxford, UK, 1st edition, 1986.

L. P. Gartner and J. L. Hiatt, Tratado de Histologia, Guanabara Koogan, Rio de Janeiro, Brazil, 1999.

J. H. Keall, N. H. Martin, and R. E. Tunbridge, “A report of three cases of accidental poisoning by sodium tellurite,” British Journal of Industrial Medicine, vol. 3, pp. 175–176, 1946.

F. C. Meotti, V. C. Borges, G. Zeni, J. B. T. Rocha, and C. W. Nogueira, “Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and ebselen for rats and mice,” Toxicology Letters, vol. 143, no. 1, pp. 9–16, 2003.

T. S. Davies and A. Monro, “Marketed human pharmaceuticals reported to be tumorigenic in rodents,” Journal of the American College of Toxicology, vol. 14, no. 2, pp. 90–107, 1995.

R. Ramachandran and S. Kakar, “Histological patterns in drug-induced liver disease,” Journal of Clinical Pathology, vol. 62, no. 6, pp. 481–492, 2009.

N. F. Chevile, “Interpretation of acute cell injury: degeneration,” in Ultraestructural Pathology: An Introduction to Interpretation, N. Cheville, Ed., chapter 2, pp. 51–79, Iowa State University Press, Ames, Iowa, USA, 1st edition, 1994.

R. H. De Meio and W. W. Jetter, “Tellurium: the toxicity of ingested tellurium dioxide for rats,” The Journal of Industrial Hygiene and Toxicology, vol. 30, no. 1, pp. 53–58, 1948.

S. L. Robbins, V. Kumar, and R. S. Cotran, Robbins and Cotran Pathologic Basis of Disease, Saunders/Elsevier, Philadelphia, Pa, USA, 8th edition, 2010.

S. Pinton, C. Luchese, E. C. Stangherlin, and C. W. Nogueira, “Acute exposure to diphenyl ditelluride causes oxidative damage in rat lungs,” Ecotoxicology and Environmental Safety, vol. 74, no. 3, pp. 521–526, 2011.

D. L. Morgan, C. J. Shines, S. P. Jeter et al., “Comparative pulmonary absorption, distribution, and toxicity of copper gallium diselenide, copper indium diselenide, and cadmium telluride in sprague–dawley rats,” Toxicology and Applied Pharmacology, vol. 147, no. 2, pp. 399–410, 1997.

G. Kimmerle, “Comparative studies on the inhalation toxicity of selenium sulfide and tellurium hexafluoride,” Archives of Toxicology, vol. 18, pp. 140–144, 1960.